Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis

Summary

The purpose of this study is to study the safety, tolerability and immunogenicity of AMG 557 following multiple subcutaneous dose administration in adults with moderate to severe psoriasis.

Timeline

Start

2011-11

Primary completion

2013-05

Completion

2013-06

Outcome

Outcome not reported

Stopped (Business): “Sponsor decision”

Drugs

Indications